Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Kielce

187 clinical trials in Kielce, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Kielce at a glance
187
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

187 trials in Kielce

Open in trial search

A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.

Alopecia areata

Recruiting

A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Almirall S.A.

Eczema nummular

Recruiting

A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Study of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.

Psoriasis

Recruiting

Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE

Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Medical University Of Lodz

Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cetirizine
  • Sponsor:Tg Therapeutics Inc.

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Kielce

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on multiple myeloma, breast cancer, and lymphoma treatments. Studies evaluate novel drug combinations and targeted therapies for improved patient outcomes.

  • Blood cancers and solid tumors
  • Targeted therapy approaches
  • Combination treatment strategies

Advanced research includes studies on prostate cancer and neuroendocrine tumors using cutting-edge therapeutic approaches.

02 Neurological Disorders

Groundbreaking research in multiple sclerosis and Alzheimer's disease. Trials evaluate new treatments for both relapsing forms of MS and psychosis associated with Alzheimer's.

  • Disease-modifying therapies
  • Neurodegeneration treatments
  • Symptom management

Focus on developing innovative therapeutic solutions for complex neurological conditions.

03 Cardiovascular and Metabolic Studies

Comprehensive research addressing hypertension, cardiovascular disease, and metabolic disorders. Studies investigate preventive approaches and novel treatment combinations.

  • Heart failure prevention
  • Blood pressure management
  • Metabolic health

Innovative trials exploring new therapeutic strategies for cardiovascular risk reduction.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.